[Febrile exanthema after nitrofurantoin administration].
D000368:Aged; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000175:diagnosis; D005076:Exanthema / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D009582:Nitrofurantoin / Q000009:adverse effects* / Q000627:therapeutic use; D010621:Phenazopyridine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy; D013411:Sulfadiazine / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D004338:Drug Combinations; D013411:Sulfadiazine; D009582:Nitrofurantoin; D011239:Prednisolone; D010621:Phenazopyridine
Febriles Exanthem nach Nitrofurantoin-Einnahme